NEW YORK (GenomeWeb News) – Sequenom said after the close of the market on Wednesday that it has filed for marketing clearance from the US Food and Drug Administration of its Impact Dx System and Impact Dx Factor V Leiden and Factor II Genotyping Test.

The system and test are intended for use in clinical laboratories.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: biobank of colorectal cancer organoids, ancient wolf genome analysis, and more.

With cloud computing becoming more attractive to researchers, Nature News offers some tips on how to get going.

In a series of articles, medical journals debate the necessity of conflict-of-interest policies.

Irwin Rose, who won the 2004 Nobel Prize in Chemistry for his work on ubiquitin-mediated protein degradation, has died.